SCHEMBL3216802

SCHEMBL3216802

COc1cccc(C=CC(=O)CC(=O)C=Cc2ccc(OC)c(O)c2)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 12/20 0.82
MAPT P10636 6/20 0.72
APP P05067 5/20 0.72
MEN1 O00255 2/20 0.69
ALDH1A1 P00352 2/20 0.69
THRB P10828 2/20 0.69
KMT2A Q03164 2/20 0.69
TDP1 Q9NUW8 2/20 0.69
CYP2D6 P10635 3/20 0.63
CYP2C9 P11712 3/20 0.63
TSHR P16473 2/20 0.63
HSD17B10 Q99714 2/20 0.63
NFE2L2 Q16236 2/20 0.63
CYP2C19 P33261 2/20 0.63
CYP1A2 P05177 2/20 0.63
CYP3A4 P08684 2/20 0.63
KDM4E B2RXH2 1/20 0.63
PTGES O14684 1/20 0.63
HDAC3 O15379 1/20 0.63
CA12 O43570 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3216786 1.00 BACE1 (0.82) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3220926 0.90 BACE1 (1.00) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3220944 0.90 BACE1 (1.00) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL15485643 0.90 BACE1 (0.81) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL29529594 0.90 BACE1 (0.81) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3222888 0.90 MAPT (0.76) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3212005 0.90 BACE1 (0.81) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3222879 0.90 MAPT (0.76) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL3211985 0.90 BACE1 (0.81) BACE1MAPTAPPMEN1ALDH1A1
SCHEMBL5599057 0.89 MAPT (0.89) BACE1MAPTAPPMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 BACE1 1/4885MAPT 8/4885APP 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.